3 Patents
- US123981872025Cd19-directed Chimeric Antigen Receptors and Uses Thereof in Immunotherapy
Nkarta, Inc.
0 cites - 0 cites
- US120124582024Genetically Modified Natural Killer Cells for Cd70-directed Cancer Immunotherapy
NKARTA, Inc.
0 cites
Nkarta, Inc.
NKARTA, Inc.